- About Us
- Contact
- Editorial Staff
- Editorial Boards
- Advertise
- Do Not Sell My Information
- Terms & Conditions
- Privacy Policy
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Latest Conference Articles
Dr Ravi Goel Previews Session on Innovations and Closing Presentation at AAO
September 26th 2022, 6:50pm
AAO: American Academy of Ophthalmology
The American Academy of Ophthalmology (AAO) annual meeting will present cutting-edge topics on retinal disease, as well as feature a presentation from historian Doris Kearns Goodwin, said Ravi Goel, MD, spokesperson for AAO and ophthalmologist at Regional Eye Associates in New Jersey.
Dr Hatim Husain Discusses HER2, Novel Therapy Exploration in Lung Cancer
September 23rd 2022, 2:24pm
Quality Care Cancer Alliance (QCCA)
During the Quality Cancer Care Alliance Summer 2022 National Leadership Summit, Hatim Husain, MD, discusses how HER2 exploration in lung cancer differs from that in breast cancer, as well as novel therapies being explored for HER2 and other disease targets.
Secukinumab Shows Rapid, Sustained Improvement of Hidradenitis Suppurativa
September 14th 2022, 6:30pm
EADV: European Academy of Dermatology and Venereology
SUNSHINE and SUNRISE trial data will be submitted to the FDA as part of Novartis’ Biologics License Application (BLA) for secukinumab in hidradenitis suppurativa.
Dr Hatim Husain: NCCN Guidelines Adjust to Meet Lung Cancer Treatment Needs
September 10th 2022, 1:18pm
Quality Care Cancer Alliance (QCCA)
Hatim Husain, MD, discusses how National Comprehensive Cancer Network (NCCN) treatment guidelines adjust to meet the treatment needs of patients with lung cancer.
Dr Hatim Husain: Biomarker Testing Is a Treatment Cornerstone in NSCLC
August 29th 2022, 5:07pm
Quality Care Cancer Alliance (QCCA)
Hatim Husain, MD, associate professor in the Department of Medicine at UC San Diego, discuses must-haves for successful biomarker testing in lung cancer—in particular, non–small cell lung cancer (NSCLC)—and how the field is adapting to the targeted treatment needs of its patients.
QCCA Panel Highlights Expansion of Innovation at Independent Community Oncology
August 17th 2022, 4:23pm
Quality Cancer Care Alliance Leadership Summit
Value management, theranostics, clinical trial access, and a mobile pharmacy are major innovations being integrated into independent community oncology practices, as highlighted at the Quality Cancer Care Alliance Summer 2022 National Leadership Summit.
Dr Anchalee Avihingsanon Addresses Trial Diversity Recruitment Difficulties
August 16th 2022, 11:00pm
Anchalee Avihingsanon, MD, PhD, HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand, is principal investigator of the ALLIANCE trial.
Dr Anchalee Avihingsanon Discusses Treatment as Prevention for HIV/HBV Coinfection
August 7th 2022, 11:27am
Anchalee Avihingsanon, MD, PhD, HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand, is principal investigator of the ALLIANCE trial from Gilead.
Social Determinants, Including Racism, Are Major Drivers of Health Inequity, Watson Says
July 31st 2022, 7:18pm
ASPC: American Society for Preventive Cardiology
Social determinants of health are major drivers of the inequities seen in health outcomes, and racism is clearly a social determinant tied to life expectancy, said Karol Watson, MD, PhD, in talk Sunday at the 2022 Congress of the American Society for Preventive Cardiology, held in Louisville, Kentucky.
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV Care
July 30th 2022, 7:38pm
ASPC: American Society for Preventive Cardiology
Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.